STAT3 and hepatocellular carcinoma: Based on these evidences, we hypothesized that the NRF2-mediated activation of the STAT3-HNF4A inflammatory loop could lead to a long-term suppression of miR-122 that increases the HCC risk among patients with cirrhosis.